Abstract
Probiotics have been suggested as a prophylactic measure in colon cancer. The aim of this study was to investigate the impact of Lactobacillus salivarius Ren (Ren) in modulating colonic microbiota structure and colon cancer incidence in a rat model after injection with 1,2-dimethyl hydrazine (DMH). The results indicated that oral administration of Ren could effectively suppress DMH-induced colonic carcinogenesis. A significant decrease in cancer incidence (87.5% to 25%) was detected in rats fed with a dose of 5 × 1010 CFU/kg bodyweight per day. Using denaturing gradient gel electrophoresis and Real-time PCR combined with multivariate statistical methods, we demonstrated that injection with DMH significantly altered the rat gut microbiota, while Ren counteracted these DMH-induced adverse effects and promoted reversion of the gut microbiota close to the healthy state. Tvalue biplots followed by band sequencing identified 21 bacterial strains as critical variables affected by DMH and Ren. Injection of DMH significantly increased the amount of Ruminococcus species (sp.) and Clostridiales bacteria, as well as decreasing the Prevotella sp. Administration of Ren reduced the amount of Ruminococcus sp., Clostridiales bacteria, and Bacteroides dorei, and increased the amount of Prevotella. Real-time PCR results were consistent with the results derived by t-value biplots. These findings suggested that Ren is a potential agent for colon cancer prevention. In conclusion, the results in the present study suggest a potential therapeutic approach based on the modulation of intestinal microflora by probiotics may be beneficial in the prevention of colorectal carcinogenesis.
Similar content being viewed by others
References
Arthur, J.C., Gharaibeh, R.Z., Uronis, J.M., Perez-Chanona, E., Sha, W., Tomkovich, S., Muhlbauer, M., Fodor, A.A., and Jobin, C. 2013. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci. Rep. 3, 2868.
Arthur, J.C., Perez-Chanona, E., Muhlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.J., Campbell, B.J., Abujamel, T., Dogan, B., Rogers, A.B., et al. 2012. Intestinal inflammation targets cancer- inducing activity of the microbiota. Science 338, 120–123.
Camp, J.G., Kanther, M., Semova, I., and Rawls, J.F. 2009. Patterns and scales in gastrointestinal microbial ecology. Gastroenterology 136, 1989–2002.
Dicksved, J., Lindberg, M., Rosenquist, M., Enroth, H., Jansson, J.K., and Engstrand, L. 2009. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J. Med. Microbiol. 58, 509–516.
Dove, W.F., Clipson, L., Gould, K.A., Luongo, C., Marshall, D.J., Moser, A.R., Newton, M.A., and Jacoby, R.F. 1997. Intestinal neoplasia in the ApcMin mouse: Independence from the microbial and natural killer (beige locus) status. Cancer Res. 57, 812–814.
Geier, M.S., Butler, R.N., and Howarth, G.S. 2006. Probiotics, prebiotics and synbiotics- A role in chemoprevention for colorectal cancer? Cancer Biol. Ther. 5, 1265–1269.
Greer, J.B. and O’Keefe, S.J. 2011. Microbial induction of immunity, inflammation, and cancer. Front Physiol. 1, 168.
Guarner, F. and Malagelada, J.R. 2003. Gut flora in health and disease. Lancet 361, 512–519.
Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., and Brummer, R.J. 2008. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104–119.
Janczyk, P., Pieper, R., Smidt, H., and Souffrant, W.B. 2010. Effect of alginate and inulin on intestinal microbial ecology of weanling pigs reared under different husbandry conditions. FEMS Microbiol. Ecol. 72, 132–142.
Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., and Forman, D. 2011. Global cancer statistics. CA Cancer J. Clin. 61, 69–90.
Kado, S., Uchida, K., Funabashi, H., Iwata, S., Nagata, Y., Ando, M., Onoue, M., Matsuoka, Y., Ohwaki, M., and Morotomi, M. 2001. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res. 61, 2395–2398.
Kumar, M., Kumar, A., Nagpal, R., Mohania, D., Behare, P., Verma, V., Kumar, P., Poddar, D., Aggarwal, P.K., Henry, C.J.K., et al. 2010. Cancer-preventing attributes of probiotics: an update. Int. J. Food Sci. Nutr. 61, 473–496.
Lepš, J. and Šmilauer, P. 2003. Multivariate analysis of ecological data using CANOCO. Cambridge University Press, Cambridge, UK.
Licht, T.R., Hansen, M., Poulsen, M., and Dragsted, L.O. 2006. Dietary carbohydrate source influences molecular fingerprints of the rat faecal microbiota. BMC Microbiol. 6 98.
Matsuki, T., Watanabe, K., Fujimoto, J., Takada, T., and Tanaka, R. 2004. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl. Environ. Microbiol. 70, 7220–7228.
Moore, W.E.C. and Moore, L.H. 1995. Intestinal floras of populations that have a high-risk of colon-cancer. Appl. Environ. Microbiol. 61, 3202–3207.
Nagengast, F.M., Grubben, M.J., and van Munster, I.P. 1995. Role of bile acids in colorectal carcinogenesis. Eur. J. Cancer 31A, 1067–1070.
Nicholson, J.K., Holmes, E., and Wilson, I.D. 2005. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 3, 431–438.
Ohigashi, S., Sudo, K., Kobayashi, D., Takahashi, O., Takahashi, T., Asahara, T., Nomoto, K., and Onodera, H. 2013. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig. Dis. Sci. 58, 1717–1726.
Onoue, M., Kado, S., Sakaitani, Y., Uchida, K., and Morotomi, M. 1997. Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats. Cancer Lett. 113, 179–186.
Piazzi, G., D’Argenio, G., Prossomariti, A., Lembo, V., Mazzone, G., Candela, M., Biagi, E., Brigidi, P., Vitaglione, P., Fogliano, V., et al. 2014. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota. Int. J. Cancer 135, 2004–2013.
Sanguinetti, C.J., Neto, E.D., and Simpson, A.J.G. 1994. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17, 914–921.
Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P., Corthier, G., Jeanne, T.V.N., and Furet, J.P. 2011. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 6, e16393.
Tannock, G.W., Munro, K., Bibiloni, R., Simon, M.A., Hargreaves, P., Gopal, P., Harmsen, H., and Welling, G. 2004. Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Appl. Environ. Microbiol. 70, 2129–2136.
Thompson-Chagoyan, O.C., Maldonado, J., and Gil, A. 2007. Colonization and impact of disease and other factors on intestinal microbiota. Dig. Dis. Sci. 52, 2069–2077.
Torres, E.A.F.D., Garbelotti, M.L., and Neto, J.M.M. 2006. The application of hierarchical clusters analysis to the study of the composition of foods. Food Chem. 99, 622–629.
Uronis, J.M., Muhlbauer, M., Herfarth, H.H., Rubinas, T.C., Jones, G.S., and Jobin, C. 2009. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 4, e6026.
Wei, H., Dong, L., Wang, T.T., Zhang, M.H., Hua, W.Y., Zhang, C.H., Pang, X.Y., Chen, M.J., Su, M.M., Qiu, Y.P., et al. 2010. Structural shifts of gut microbiota as surrogate endpoints for monitoring host health changes induced by carcinogen exposure. FEMS Microbiol. Ecol. 73, 577–586.
White, I.R., Pickford, R., Wood, J., Skehel, J.M., Gangadharan, B., and Cutler, P. 2004. A statistical comparison of silver and SYPRO Ruby staining for proteomic analysis. Electrophoresis 25, 3048–3054.
Zhang, M., Qiao, X.W., Zhao, L., Jiang, L., and Ren, F.Z. 2011. Lactobacillus salivarius REN counteracted unfavorable 4-nitroquinoline- 1-oxide-induced changes in colonic microflora of rats. J. Microbiol. 49, 877–883.
Zhang, M., Wang, F., Jiang, L., Liu, R.H., Zhang, L., Lei, X.G., Li, J.Y., Jiang, J.L., Guo, H.Y., Fang, B., et al. 2013. Lactobacillus salivarius REN inhibits rat oral cancer induced by 4-nitroquioline 1-oxide. Cancer Prev. Res. 6, 686–694.
Zhu, J., Zhu, C., Ge, S., Zhang, M., Jiang, L., Cui, J., and Ren, F. 2014. Lactobacillus salivarius Ren prevent the early colorectal carcinogenesis in 1, 2-dimethylhydrazine-induced rat model. J. Appl. Microbiol. 117, 208–216.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work
Rights and permissions
About this article
Cite this article
Zhang, M., Fan, X., Fang, B. et al. Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1, 2-dimethylhydrazine-induced rat model. J Microbiol. 53, 398–405 (2015). https://doi.org/10.1007/s12275-015-5046-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-015-5046-z